A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache

NCT02163993 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

414

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine Headache

Interventions

DRUG: Galcanezumab
DRUG: Placebo

Sponsor

Eli Lilly and Company